Robert Postlethwaite
Geen lopende functies
Profiel
Robert Postlethwaite worked as a Director at AgeneBio, Inc. and as an Executive Partner at Cardinal Equity Partners LLC.
He also worked at Pinsent Curtis Biddle in 2004-2005.
Eerdere bekende functies van Robert Postlethwaite
| Bedrijven | Functie | Einde |
|---|---|---|
AgeneBio, Inc.
 AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Directeur/Bestuurslid | - |
Cardinal Equity Partners LLC
 Cardinal Equity Partners LLC Investment ManagersFinance Cardinal Equity Partners LLC (Cardinal Equity Partners) is a private equity firm founded in 1993 by John F. Ackerman, James L. Smeltzer and Peter J. Munson. The firm is headquartered in Indianapolis, Indiana. | Private Equity Investor | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Cardinal Equity Partners LLC
Cardinal Equity Partners LLC Investment ManagersFinance Cardinal Equity Partners LLC (Cardinal Equity Partners) is a private equity firm founded in 1993 by John F. Ackerman, James L. Smeltzer and Peter J. Munson. The firm is headquartered in Indianapolis, Indiana. | Finance |
AgeneBio, Inc.
AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Health Technology |
